NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 289 filers reported holding NATERA INC in Q3 2022. The put-call ratio across all filers is 1.19 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $536,089 | +9.5% | 12,115 | +20.4% | 0.01% | +14.3% |
Q2 2023 | $489,617 | -12.8% | 10,062 | -0.5% | 0.01% | -22.2% |
Q1 2023 | $561,307 | +54.0% | 10,110 | +11.4% | 0.01% | +50.0% |
Q4 2022 | $364,543 | +0.7% | 9,075 | +9.8% | 0.01% | 0.0% |
Q3 2022 | $362,000 | +60.9% | 8,265 | +49.8% | 0.01% | +100.0% |
Q1 2022 | $225,000 | -88.9% | 5,519 | -74.6% | 0.00% | -88.9% |
Q4 2021 | $2,029,000 | -26.9% | 21,734 | -12.7% | 0.03% | -30.8% |
Q3 2021 | $2,774,000 | +9.0% | 24,887 | +11.0% | 0.04% | +8.3% |
Q2 2021 | $2,545,000 | +18.5% | 22,417 | +6.0% | 0.04% | +9.1% |
Q1 2021 | $2,147,000 | +20.4% | 21,147 | +18.1% | 0.03% | +10.0% |
Q4 2020 | $1,783,000 | +88.9% | 17,911 | +37.1% | 0.03% | +66.7% |
Q3 2020 | $944,000 | +181.0% | 13,061 | +94.3% | 0.02% | +157.1% |
Q2 2020 | $336,000 | +394.1% | 6,722 | +196.8% | 0.01% | +250.0% |
Q1 2020 | $68,000 | +172.0% | 2,265 | +203.2% | 0.00% | +100.0% |
Q4 2019 | $25,000 | -7.4% | 747 | -10.9% | 0.00% | 0.0% |
Q3 2019 | $27,000 | +42.1% | 838 | +24.9% | 0.00% | – |
Q2 2019 | $19,000 | +90.0% | 671 | +38.1% | 0.00% | – |
Q1 2019 | $10,000 | +100.0% | 486 | +38.1% | 0.00% | – |
Q4 2018 | $5,000 | – | 352 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blue Water Life Science Advisors, LP | 797,436 | $35,286,543 | 33.31% |
Kynam Capital Management, LP | 3,003,668 | $132,912,309 | 21.74% |
Eversept Partners, LP | 2,492,636 | $110,299,143 | 9.33% |
Sofinnova Investments, Inc. | 3,100,560 | $137,199,780 | 8.66% |
Eagle Health Investments LP | 595,694 | $26,359,460 | 5.81% |
BEACONLIGHT CAPITAL, LLC | 259,865 | $11,499,026 | 4.97% |
Lagoda Investment Management, L.P. | 165,465 | $7,321,826 | 4.81% |
Tri Locum Partners LP | 274,795 | $12,159,679 | 3.89% |
Bain Capital Life Sciences Investors, LLC | 700,197 | $30,983,717 | 3.46% |
SAMLYN CAPITAL, LLC | 4,400,226 | $194,710,000 | 3.18% |